B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CYP19A1

MOLECULAR TARGET

cytochrome P450 family 19 subfamily A member 1

UniProt: P11511NCBI Gene: 1588102 compounds

CYP19A1 (cytochrome P450 family 19 subfamily A member 1) is targeted by 102 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CYP19A1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Letrozole3.9953
2Fadrozole3.7441
3Anastrozole3.0019
4Kaempferols2.309
5chrysin2.208
6Androstenedione2.208
7Apigenin 5,7,4'-trihydroxy-flavone,1.795
8Clotrimazole1.795
9Methylene Blue1.614
10Testosterone1.614
11Bortezomib1.614
12cycloheximide1.614
13Ethidium1.614
14Fulvestrant1.614
15Lovastatin1.614
16Miconazole1.614
17Reserpine1.614
18Spironolactone1.614
19Vitamin1.393
20Dactinomycin1.393
21Dihydrotestosterone1.393
22Disulfiram1.393
23Hexachlorophene1.393
24mg6241.393
25Ouabain1.393
26Rotenone1.393
27stx641.393
28Acetaldehyde1.102
29Amoxapine1.102
30Astemizole Antihistamine drug now withdrawn from1.102
31Azacitidine1.102
32Azacitidine1.102
33Celecoxib1.102
34Cetylpyridinium Cationic bactericidal surfactant used as1.102
35Chlorhexidine1.102
36Daunorubicin1.102
37Digoxin1.102
38Dinitrochlorobenzene1.102
39Emetine1.102
40Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as1.102
41Flutamide1.102
42Nisoldipine1.102
43Nitrofurantoin1.102
44ns3981.102
45Potassium Dichromate Chromic acid (H2Cr2O7), dipotassium salt.1.102
46Toxaphene1.102
47Trabectedin1.102
48Troglitazone1.102
49Atorvastatin0.691
50Kaempferols0.691

Showing top 50 of 102 compounds. Use the BiohacksAI search to explore all CYP19A1 modulators.

About CYP19A1 as a Drug Target

CYP19A1 (cytochrome P450 family 19 subfamily A member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 102 compounds with documented CYP19A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CYP19A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.